Tobam Bio Techne Corp Transaction History

Tobam

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$80.67 - $352.29 $29,283 - $127,881	363 Added 125.61%	652 $54,000
Q3 2022 Nov 02, 2022	BUY	$282.54 - $391.85 $29,666 - $41,144	105 Added 57.07%	289 $82,000
Q2 2022 Aug 02, 2022	SELL	$322.67 - $449.65 $3,226 - $4,496	-10 Reduced 5.15%	184 $64,000
Q1 2022 Apr 25, 2022	BUY	$353.85 - $487.79 $14,507 - $19,999	41 Added 26.8%	194 $84,000
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $37,369 - $45,265	84 Added 121.74%	153 $74,000
Q2 2021 Aug 11, 2021	SELL	$387.35 - $450.26 $33,699 - $39,172	-87 Reduced 55.77%	69 $31,000
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $36,226 - $44,141	156 New	156 $39,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.